Urethral cancer treatment
Urethral cancer is a relatively rare malignant tumour that occurs mainly in women. It can be localised in the distal or proximal parts of the external opening of the urethra. The risk group is women aged 50-60 after the cessation of menstruation (in postmenopause). Treatment consists mainly of surgery and drug therapy (immune and chemotherapy).
Cancer of the urethra is a malignant neoplasm in the walls of the urinary organ. The tumour can be localised both in the upper and lower part of the urethra. Doctors report that the most common urethral cancer in women - is due to the anatomical structure of the female urethra. It is noticeably shorter than a man's, so it is more prone to neoplasm formation. At the same time, cancer cells spread quickly with the flow of lymph. In men, the pathology also can occur, but it is much less expected and manifests a little differently.
Malignant neoplasms of the urinary tract are rare cases. Their share in general oncological pathology is less than 1%, and the average doctor rarely encounters them. So it partly explains the large percentage of patients with advanced forms.
The common causes that provoke the disease include progressive bladder cancer, the presence of chronic or inflammatory conditions (including venereal), and age over 60 years. It was also noticed that the disease occurs more often in representatives of the Caucasian race.
The symptoms, depending on the form, include small translucent secretions (in the early stages) and, bloody-purulent secretions (in the later stages), difficult urination (up to a complete delay). The diagnosis can be confirmed by self-determining thickening and pain during urination. Cancer is characterised by the formation of fistulas and purulent cavities near the urethra, swelling of the legs and genitals, incontinence, etc.
Modern equipment makes it possible to detect the disease at the very beginning. The doctors use endoscopic examination to visualise the urethra along its entire length and take a biopsy (a tissue fragment for histological examination). In addition, urine tests, ultrasound of the pelvis and extraperitoneal space, CT, and MRI are necessary to differentiate the disease from other pathologies with similar symptoms.
Many urologists and oncologists confirm that surgical treatment is the only effective way to fight cancer. The principles of the operation are determined by the gender, location and the spread of the malignant process. Transurethral interventions are one of the best options for some patients. But this is possible only in the early stages. The procedure provides minimal trauma and preserves organ function and quality of life. In addition to surgery, patients often require additional measures: chemotherapy and immunotherapy.
Where can I get Urethral cancer treatment?
What are the best clinics for Urethral cancer treatment?
Who are the best doctors for Urethral cancer?
Prof. Dr. med. Jurgen Gschwend from University Hospital rechts der Isar Munich
Dr. med. Holger Heidenreich from Academic Hospital Bundeswehr Berlin
Prof. Dr. med. Martin Kriegmair from Urological Clinic Munich-Planegg
Dr. med. Nathan Kaminski from Urology Clinic Wiener Platz & Grunwald Munich
Prof. Dr. med Harald-Robert Bruch, MSc, PhD from Oncological and Haematological Praxis Clinic Bonn